$HeartBeam (BEAT.US)$ HeartBeam Achieves Major Milestone with FDA Submission for its Groundbreaking 12-Lead ECG Synthesis Software Wednesday, 29th January at 8:31 am HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced it has submitted a 510(k) application to the U.S. Food and Drug Administration (FDA) for the Company's groundbreaking 12-lead electrocardiogram (ECG) synthesis software des...
HeartBeam Stock Forum
HeartBeam Achieves Major Milestone with FDA Submission for its Groundbreaking 12-Lead ECG Synthesis Software
Wednesday, 29th January at 8:31 am
HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced it has submitted a 510(k) application to the U.S. Food and Drug Administration (FDA) for the Company's groundbreaking 12-lead electrocardiogram (ECG) synthesis software des...
No comment yet